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Background: Prophylactic antibiotics are used to prevent postoperative infections after caesarean section. Studies
have suggested that the timing of prophylaxis plays an important role. Over the years, the role of the
anaesthesiologist in the administration of prophylactic antibiotics has become prominent. Therefore, there is an
increasing need for anaesthesia providers to understand the rationale of antibiotic prophylaxis. We therefore sought
to compare the effect of antibiotics prophylaxis within 1 hour before skin incision and after skin incision on the
incidence of postoperative infections in patients undergoing caesarean section at Mulago Hospital.
Methods: We conducted a single-blind randomised clinical trial conducted at Mulago Hospital evaluating 464
patients undergoing emergency caesarean section. Patients were randomly assigned a group number that allocated
them to either arm of the study. They received the same prophylactic antibiotic according to their allotment, that
is, either within 1 hour before skin incision or after skin incision as per current standards of practice in Mulago Hospital.
They were followed up to detect infection up to 10 days postoperatively. The primary outcome was postoperative
infection. The data collected were analysed with STATA version 12 using univariate and bivariate analysis.
Results: The risk of overall postoperative infection was significantly lower when prophylaxis was given within an hour
before incision (RR O.77, 95% CI 0.62–0.97). We also found endometritis to be significantly reduced in the pre-incision
group (RR 0.62; 95% CI 0.39–0.99; P value 0.036).
Conclusions: Giving prophylactic antibiotics before skin incision reduces risk of postoperative infection, in particular of
endometritis.
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A 2006 WHO systematic review of the causes of maternal
death worldwide estimated that 9.7% of maternal deaths
in Africa were due to puerperal sepsis [1]. One of the most
important risk factors of postpartum infection in both de-
veloped and developing countries is caesarean section [2].
The second most common cause of maternal mortality is
infection, and it contributes to 15% of the causes of
maternal mortality in Uganda [3]. In low-income settings,
improving the safety and care provided when performing
a caesarean section can improve maternal and neonatal
outcomes, which is in line with Millennium Development
Goals number 4 and 5 [4].
Caesarean section is one of the most common surgical
procedures performed in medical practice worldwide,
and it is the most common surgical procedure per-
formed in obstetrics and gynaecology practice at Mulago
hospital. On average Caesarean section account for about
24% of 35 000 births per annum managed by Mulago
hospital. Women giving birth by caesarean section present
a 5- to 20-fold greater risk of infection than women giving
birth by vaginal delivery [5]. Rates of severe wound infec-
tion can be as high as 25% [6]. One of the measures applied
to prevent infectious complications following caesarean
section is the use of prophylactic antibiotics [7,8]. The
purpose of antibiotic prophylaxis in surgical procedures
is not to sterilise tissues but to reduce colonisation pressure
of microorganisms introduced at the time of the operation
to a level that can be overcome by the patient’s immune
system [9,10].
Whether antibiotic prophylaxis for caesarean section
should be administered prior to the skin incision or at
the time of the umbilical cord clamping remains contro-
versial [11]. Traditionally, prophylaxis has been delayed
in an effort to avoid masking a neonatal infection and to
prevent an unnecessary septic workup. However, recent
evidence shows no increase in neonatal sepsis, sepsis
investigations, or length of stay [12-14]. A meta-analysis
by Constantine et al. published in 2008 supports the use
of antibiotic prophylaxis prior to caesarean incision to
reduce total infectious morbidity without negative effects
on neonatal outcomes [14]. Though more recent studies
suggest there may be long-term effects of antibiotic
prophylaxis on neonates, these still need to be validated
by long-term follow-up studies of neonates exposed to
antibiotics [15,16]. Thus, the American Congress of Ob-
stetricians and Gynaecologists announced, in 2010, a
new recommendation for antibiotic prophylaxis during
caesarean delivery [17]. The new recommendation states
that women giving birth by caesarean section should re-
ceive antibiotics routinely within 1 hour before the start
of surgery. In the case of an emergency caesarean deliv-
ery, prophylaxis should be started as soon as possible.
Further, a survey conducted in 2011 in the United Statesshowed that 85% percent of patients received antibiotics
preoperatively [18], indicating a change in the current
practices in the country owing to the new recommenda-
tion. Very little is known about this practice in low-income
countries in Africa, and in Uganda in particular.
At Mulago Hospital, there is evidence of increased post-
operative infection in post-caesarean section patients as
per an unpublished dissertation by Ssebuko. Currently
there is no clear indication as to when antibiotic prophy-
laxis was administered and whether it contributed to the
results of postoperative infection. Therefore, we sought to
compare the relationship of timing of the administration
of prophylactic antibiotics, within 1 hour before skin inci-
sion or after skin incision, and determine if either practice
would affect the incidence of infection post-caesarean
section.
Methods
Study design and setting
We conducted a single-blind randomised clinical trial,
which was registered in the Pan African Clinical Trial
Registry (Reference number PACTR201311000610495).
We received ethical approval from our International
Review Board called School of Medicine Research and
Ethics Committee, and the study was conducted at
Mulago National Referral Hospital in Kampala, Uganda,
which is situated in Kampala, 2 km from the city centre. It
is also the Makerere University Medical School teaching
hospital, and it serves as a national referral hospital, as
well as a general hospital for the people of Kampala and
its surroundings. The obstetric and gynaecological wards
are located in the 5th floor, and they have two operating
theatres: one for emergency cases from the labour ward
and the other for elective cases, the Gynaecological
theatre.
The sample size calculation was based on a similar
study done in South Carolina, with an effect size of 40%
[9]. For our study to have an 80% power and level of sig-
nificance of 0.05, 421 patients were required. We added
10% to that value in case some were some patients were
lost to follow-up, resulting in a total sample size of 464
patients.
Eligibility
We included patients from the labour ward who had been
scheduled for emergency caesarean section and provided
written informed consent. Patients with evidence of current
infection, that is, with fever, foul smelling discharge, already
taking antibiotics, and those with allergic reaction to cepha-
losporins were excluded.
Upon providing informed consent, patients were allo-
cated intervention according the number picked from ran-
domisation envelopes. The patients were given consent
forms that had an information sheet about the study and it
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in agreement. We created four blocks of 116 patients with
computer-generated numbers. Each number was accom-
panied by an A or B to specify which group a patient
belonged to. Each block was kept in different sealed enve-
lopes. Patients in group A were administered ceftriaxone 2
g intravenously 15 to 60 minutes before the skin incision,
and those in group B were administered the same dose
after performing the skin incision. The patients were
blinded to the timing of the treatment received, but the
investigator was not blinded as the timing of antibiotic
administration had to be known. However, the investiga-
tors conducting the follow-up were blinded.
Patients were followed up in the postnatal ward on
each of the 3 postoperative days to assess for signs and
symptoms of infection, and their temperature was taken
using digital thermometers. Infection was defined as
endometritis (uterine tenderness, maternal tachycardia,
fever), wound infection (surgical site infection according
to criteria by the American Centre for Disease Control)
[19] and fever (temperature greater than 37.8°C after 24
hours postoperatively). The last assessment for infectionFigure 1 Patient flow diagram.was performed on the 10th postoperative day as this was
the date for patient’s postnatal check-up.Outcomes
The primary outcome was either the presence or absence
of infection (either endometritis, fever morbidity or wound
infection) during the observation period, which lasted until
the 10th postoperative day. Secondary outcomes were
neonatal outcomes reported during the time of observa-
tion, including any admission to the neonatal intensive
care unit and treatment for infection. Infection was treated
as per protocols from the Department of Obstetrics and
Gynaecology.Data collection
Data were collected using interviewer-administered pre-
tested questionnaires. Filled in questionnaires were checked
daily for completeness and accuracy by the principal inves-
tigator, and errors were corrected before data entry on
Epidata 3.1 (The EpiData Association, Odense, Denmark).
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Research assistants were blinded as to which group pa-
tients were in. They were trained on how to assess and
ask questions regarding symptoms, and we ensured that
they were conversant with taking vital signs.
Data analysis
Data were exported and analysed using STATA software
version 12 (StataCorp Inc., Texas, USA). We conducted
an interim analysis after half of the sample size was
recruited.
Univariate analysis was used for basic characteristics of
participants expressed as categorical and continuous vari-
ables, including age. Continuous variables were expressed
as means and standard deviations, while categorical data
were expressed as frequencies with their respective




Age group in years
18–25 124 (56.11) 12
26–35 88 (39.82) 81
>35 9 (4.02) 9
Diabetes
No 210 (99.53) 21
Yes 1 (0.47) 3
HIV status
Not known 26 (12.32) 29
Positive 23 (10.90) 25
Negative 162 (76.78) 16
Chronic medication
No 190 (90.05) 19
Yes 21 (9.95) 25
Previous Operation
No 107 (50.71) 12
Yes 104 (49.29) 95
Type of incision
Midline 106 (50.24) 86
Pfannenstiel 105 (49.76) 13
Anaesthesia given
General 32 (15.17) 62
Spinal 179 (84.83) 15
Intraoperative complications
No 200 (94.79) 20
Yes 11 (5.21) 15
N, number; HIV, human immunodeficiency virus.The risk of postoperative infection in the two groups
was assessed by taking the number of new infections as
the numerator and the denominator was the total num-
ber of participants in each group. Binomial regression
was used to estimate the risk ratio, with respective 95%
confidence intervals, by taking the risk of infection
among those who received antibiotics preoperatively as
the numerator and postoperation risk as the denomin-
ator. The same methods were used to estimate the risk
ratio of neonatal outcomes between the two groups. In
all analyses, a p-value of < 0.05 was considered statistically
significant.
Adverse event monitoring
A Data Safety Management Board, comprising an anaes-
thesiologist, obstetrician, paediatrician and pharmacist,
was to be notified of adverse events. Adverse events wereboth groups
Overall N (%) P value
(%)Post-incision
(%)
1 (57.35) 245 (56.71)
(38.39) 169 (39.12)
(4.27) 18 (4.17) 0.953
8 (98.64) 428 (99.07)
(1.36) 4 (0.93) 0.338
(13.12) 55 (12.73)
(11.31) 48 (11.11)
5 (75.57) 329 (76.16) 0.955
6 (88.69) 386 (89.35)
(11.31) 46 (10.65) 0.647
6 (57.01) 233 (53.94)
(42.99) 199 (46.06) 0.189
(38.91) 192 (44.44)
5 (61.09) 240 (55.56) 0.018
(28.05) 94 (21.76)
9 (71.95) 338 (78.24) 0.001
6 (93.21) 406 (93.98)
(6.79) 26 (6.02) 0.492
Table 2 Measure of association of incidence of infection with significant general characteristics
Variable Measure of association
Crude RR (95% CI) Adjusted RR (95% CI)* P value
Overall infections 0.77 (0.62–0.97) 0.78 (0.62–0.97) 0.029
Pfannenstiel incision 0.90 (0.72–1.12) 0.93 (0.74–1.15) 0.503
General anaesthesia 0.98 (0.75–1.26) 1.01 (0.78–1.32) 0.918
*Adjusted for Overall infections, Pfannenstiel incision and general anaesthesia.
RR, risk ratio; CI, confidence interval.
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more than 15% of study patients. If this occurred, the
study would be stopped and events treated as per protocol
for management of neonatal sepsis in the Department of
Paediatrics. At interim analysis, there were no reasons to
stop the study because there were no reports of adverse
neonatal outcomes. The study was continued until the
sample size was achieved.
Results
In this study, we assessed 493 patients who were sched-
uled for caesarean section between January 2014 and
March 2014. Twenty-nine patients were excluded from
the study: 21 did not meet the inclusion criteria and
eight refused participation in the study. The remaining
464 patients were then randomised and received inter-
vention as per allocated groups A (Pre-incision) or B
(Post-incision). Of these, only 432 were analysed as the
other 32 were lost to follow-up (Figure 1). This difference
did not affect the power of the study because the sample
size calculation indicated that 421 patients were needed
for a power of 80% and level of significance of 0.05.
The distribution and characteristics of patients are
shown in Table 1. The general characteristics were gen-
erally evenly distributed, except for type of incision and
type of anaesthesia given, which were significantly differ-
ent (P values < 0.05, respectively). These variables were
considered later in a multivariate model to determine
their effects on study outcomes (Table 2).
On average, patients in group A received prophylaxis
[mean (standard deviation)] 26.09 (9.67) minutes before
the skin incision was performed. This timing falls within
the 15 to 60 minutes that was specified in the protocol
for this group. On average, patients in group B received
prophylaxis 13.00 (12.93) minutes after the skin incision
(Table 3).
The primary outcomes are presented in Table 4. Overall,
infection was observed in 65.9% (139/211) of patients in
group A and in 85.1% (188/221) of patients in group B,Table 3 Mean time between incision and prophylaxis and ave
Variable Overall
Time difference between prophylaxis and incision (minutes) 19.40 (1
Length of operation (minutes) 60.71 (1
The data are presented as mean (standard deviation).and the difference between groups was statistically signifi-
cant (risk ratio [RR] 0.77; 95% confidence interval [CI]
0.62–0.97; P value = 0.022). Wound infection was ob-
served in 51.2% (108/211) in group A and 61.5% (136/221)
in group B. Endometritis was seen in 14.7% (31/211) in
group A and 23.5% (52/221) in group B, and the differ-
ence in the risk of endometritis was statistically signifi-
cant (RR 0.62;95% CI 0.39–0.99; P = 0.036). Neonatal
outcomes were seen in 1.4% (3/211) in group A and
0.4% (1/221) in group B, but the difference between
groups was not statistically significant. These were neo-
nates admitted into the neonatal intensive care unit
during the observation period and were treated for
infection.
A multivariate model was used to assess the general
characteristics of patients that were not evenly distrib-
uted between the groups, but that were significantly
different. These included type of incision (P = 0.018)
and type of anaesthesia (P = 0.001). As presented in
Table 2, the risk of overall infection remained signifi-
cantly lower in group A compared with group B, even
after controlling for effects of Pfannenstiel incision and
general anaesthesia.
Discussion
We conducted a single-blind randomised clinical trial to
compare the effect of the time of administration of
prophylactic antibiotics on the risk of postoperative
infection.
Primary outcome
We found that the incidence of overall infection in
group A (pre-incision) was lower than in group B (post-
incision). In this study, we considered wound infection,
endometritis and fever, occurring within an observation
period of 10 days post-caesarean section as postoperative
infections. Our results show that there was a statistically
significant difference in this risk ratio, with less infection
in the pre-incision group. Further, endometritis wasrage length of operation in both groups
Pre-incision Post-incision Mean difference P value
3.18) 26.09 (9.67) 13.00 (12.93) 13.09 0.001
20.7) 56.49 (168.6) 64.74 (36.9) 8.25 0.478
Table 4 Association between infection and time of antibiotic administration
Outcomes Randomisation groups Risk ratio (95% CI) P value
Pre-incision Post-incision
Total population = 211 Total population = 221
Events Risk Events Risk
Postoperative infections
Overall infections 139 0.659 188 0.851 0.77 (0.62–0.97) 0.022
Wound infection 108 0.512 136 0.615 0.83 (0.64–1.08) 0.153
Endometritis 31 0.147 52 0.235 0.62 (0.39–0.99) 0.036
Neonatal outcomes* 3 0.014 1 0.004 3.14 (0.25–164.95) 0.352
*Admission to the Neonatal Intensive Care Unit and treatment for infection;
CI, confidence interval.
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whereas the between-group difference for wound infection
was not statistically significant. These results are in ac-
cordance with the results of previous studies conducted in
the United States [14,18,20]. None of the patients devel-
oped fever. It is possible that fever could have been truly
absent or that its presence was masked by the pain control
medication administered to all the patients, which were
also antipyretic agents.
We found that risk of postoperative infection was
higher in comparison with similar studies performed in
different settings in developed countries [14,18,20].
Thus, we consider that greater efforts are still needed in
aims to reduce the risk of post-caesarean infections. Our
study only focused on one aspect of preventative mea-
sures—that is, the use prophylactic antibiotics. However,
other measures, for example, adherence to aseptic pro-
cedures and quality of disinfectants need to be explored
in this setting as well.
Secondary outcome
The proportions of adverse neonatal outcomes were
1.4% and 0.4% in the pre-incision and post-incision
groups, respectively. These were neonates admitted into
the neonatal intensive care unit during the observation
period and were treated for infection. One of the neo-
nates that presented infection in the pre-incision group
was admitted into the neonatal intensive care unit for
intra-partum asphyxia. However, the outcome was not
statistically significant, indicating that the timing of
prophylaxis did not affect neonatal outcomes signifi-
cantly. The entire neonatal period cannot be accounted
for because the follow-up period in this study consisted
of only 10 postoperative days. Thus, it is unknown if
there were any long-term adverse effects, and this aspect
needs to be explored further.
The diagnosis of infection in this study was based on
clinical signs and symptoms. However, the quality of the
study could have been improved if laboratory investiga-
tions were used. This was not planned as part of theprotocol because the study was designed as a pragmatic
clinical trial that mirrored local resources. When the
patients were discharged to be followed up on day 10,
we had no control of their environment and whether
they took other medication. We consider this another
limitation of the study because this factor may have
affected the outcome, and this aspect was not explored
in this study. Additionally, although some patients were
lost to follow-up, the power of study was not affected
because the number of patients lost was lower than that
estimated by the sample size calculation. We, however,
admit that another serious limitation to this study was
its single-blind design.
Conclusions
Administration of prophylactic antibiotics within 1 hour
before skin incision significantly reduced the overall
incidence of postoperative infections. Regarding the dif-
ferent types of infection, endometritis was significantly
reduced. There were no significant adverse neonatal
outcomes associated with the timing of antibiotic
prophylaxis.
Based on the results of this study, we can recom-
mend that prophylactic antibiotics be administered
within 1 hour before skin incision in patients scheduled to
undergo caesarean section in order to reduce the overall
incidence of postoperative infection at Mulago Hospital.
Additionally, we recommend the conduct of further
investigations to determine other means of prevention of
postoperative infections in an effort to reduce the inci-
dence rate.
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